Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 11,263 shares at $39.29 ($445K) on 2016-02-29, disclosed to the SEC on 2016-03-02.
Scheduled sale ($445k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.29 | 443 | $17K | 3.9% |
| 2 | $39.29 | 1,100 | $43K | 9.7% |
| 3 | $39.52 | 9,720 | $384K | 86.4% |
| Total | $39.49 avg | 11,263 | $445K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |